Frontiers in Nuclear Medicine

Original Research

Published on 10 May 2022

Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis – the Easy DOTA-Zoledronate

in Radiopharmacy and Radiochemistry

Lukas Greifenstein
Nils Engelbogen
Domokos Máthé
Tilmann Grus
Frank Rösch
Ralf Bergmann

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.870910

2,741 views
1 citation

Perspective

Published on 03 May 2022

An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer

in Radionuclide Therapy

Bastiaan M. Privé
Constantijn H. J. Muselaers
Inge M. van Oort
Marcel J. R. Janssen
Steffie M. B. Peters
Willemijn A. M. van Gemert
Maike J. M. Uijen
Melline M. G. Schilham
J. P. Michiel Sedelaar
Harm Westdorp

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.863101

5,598 views
6 citations

Editorial

Published on 25 Apr 2022

Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives

in PET and SPECT

Antonia Dimitrakopoulou-Strauss
Christos Sachpekidis
Constantin Lapa

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.904502

1,480 views

Original Research

Published on 14 Apr 2022

Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends

in Radiopharmacy and Radiochemistry

Claus Zippel
Johannes Ermert
Marianne Patt
Franz Josef Gildehaus
Tobias L. Ross
Gerald Reischl
Torsten Kuwert
Christoph Solbach
Bernd Neumaier
Oliver Kiss

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.850414

17,003 views
6 citations

Original Research

Published on 07 Apr 2022

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma

in PET and SPECT

Vincent Rebière
Meriem Maajem
Ronan Le Calloch
Leela Raj
Anne-Sophie Le Bris
Mohamed Malou
François Salmon
Isabelle Quintin-Roué
Adrian Tempescul
David Bourhis

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.829138

3,114 views
2 citations

Review

Published on 25 Mar 2022

The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers

in Radiopharmacy and Radiochemistry

E. Johanna L. Stéen
Danielle J. Vugts
Albert D. Windhorst

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.853475

11,111 views
35 citations

Review

Published on 21 Mar 2022

18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation

in PET and SPECT

Olwethu Mbakaza
Mboyo-Di-Tamba Willy Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.847810

15,697 views
11 citations

Case Report

Published on 15 Mar 2022

Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report

in Radionuclide Therapy

Nathalie Rouiller
Marie Nicod Lalonde
Gerasimos P. Sykiotis

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.858062

3,638 views
2 citations

Review

Published on 08 Mar 2022

F-18 Fluoro-2-Deoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Melanoma: Normal Variants, Pitfalls, and Artifacts

in PET and SPECT

Jaleelat I. Momodu
Mboyo Di Tamba Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.835404

3,993 views
4 citations

Review

Published on 03 Mar 2022

Normal Variants and Pitfalls of 18F-FDG PET/CT Imaging in Pediatric Oncology

in PET and SPECT

Khushica Purbhoo
Mboyo Di-Tamba Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.825891

11,638 views
11 citations

Mini Review

Published on 25 Feb 2022

Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy

in PET and SPECT

Johannes von Hinten
Malte Kircher
Alexander Dierks
Christian H. Pfob
Takahiro Higuchi
Martin G. Pomper
Steven P. Rowe
Andreas K. Buck
Samuel Samnick
Rudolf A. Werner

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.801792

3,620 views
6 citations

Review

Published on 22 Feb 2022

18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review

in PET and SPECT

Charles Mesguich
Cyrille Hulin
Valérie Latrabe
Axelle Lascaux
Laurence Bordenave
Elif Hindié

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.808627

6,846 views
10 citations

Review

Published on 21 Feb 2022

Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging

in PET and SPECT

Nico Malan
Mboyo-di-Tamba Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.825512

29,284 views
16 citations

Case Report

Published on 16 Feb 2022

Case Report: Skeletal Muscle Lymphoma as a Result of Slow Centrifugal Migration of Untreated Primary Neurolymphomatosis?

in PET and SPECT

Sona Balogova
Radoslav Greksak
Magdalena Mizickova
Lucia Noskovicova
Pavel Babal
Ludovit Lukac

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.804421

2,315 views

Original Research

Published on 14 Feb 2022

Estimation of the Internal Dose Imparted by 18F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography

in Dosimetry and Radiation Safety

Thititip Tippayamontri
Esteban Betancourt-Santander
Brigitte Guérin
Roger Lecomte
Benoit Paquette
Léon Sanche

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.815141

5,037 views
2 citations

Review

Published on 07 Feb 2022

Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PET/CT Imaging

in PET and SPECT

Nico Malan
Mboyo-Di-Tamba Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.825486

34,096 views
17 citations

Review

Published on 01 Feb 2022

Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?

in Radionuclide Therapy

Mboyo Di Tamba Vangu
Jaleelat I. Momodu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.826046

10,033 views
4 citations

Review

Published on 21 Jan 2022

Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid Carcinoma

in Radionuclide Therapy

Friederike Eilsberger
Markus Luster
Christoph Reiners

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.797522

2,751 views
1 citation

Original Research

Published on 20 Jan 2022

Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase

in Radiopharmacy and Radiochemistry

David J. Donnelly
Sean Preshlock
Tanpreet Kaur
Tritin Tran
Thomas C. Wilson
Karim Mhanna
Bradford D. Henderson
Daniel Batalla
Peter J. H. Scott
Xia Shao

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.820235

6,875 views
11 citations

Review

Published on 17 Jan 2022

F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Artifacts in the Abdomen and Pelvis

in PET and SPECT

Mboyo D. T. Vangu
Jaleelat I. Momodu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.826109

28,602 views
14 citations

Review

Published on 06 Jan 2022

Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma

in PET and SPECT

Ryogo Minamimoto

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.796357

3,208 views
3 citations

Case Report

Published on 14 Dec 2021

Case Report: Pleuropulmonary Blastoma in a 2.5-Year-Old Boy: 18F-FDG PET/CT Findings

in PET and SPECT

Dan Ruan
Long Sun

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.780485

3,597 views
5 citations

Original Research

Published on 13 Dec 2021

Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR

in Radiopharmacy and Radiochemistry

Troels E. Jeppesen
Marina Simón
Josephine Torp
Line B. S. Knudsen
Julie Maja Leth
François Crestey
Michael Ploug
Jesper T. Jørgensen
Jacob Madsen
Matthias M. Herth

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.799533

4,294 views
4 citations

Original Research

Published on 30 Nov 2021

Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence

in Radionuclide Therapy

Cynara Rena Salmont Higuchi
Paula Fernanda
Paulo Alonso Jurnior
Fernanda Accioly Andrade
Rossana Corbo
Mario Vaisman
Fernanda Vaisman
Daniel Bulzico

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2021.785768

3,012 views
3 citations

196 articles

articles

Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis – the Easy DOTA-Zoledronate

An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer

Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives

Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma

The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers

18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation

Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report

F-18 Fluoro-2-Deoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Melanoma: Normal Variants, Pitfalls, and Artifacts

Normal Variants and Pitfalls of 18F-FDG PET/CT Imaging in Pediatric Oncology

Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy

18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review

Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging

Case Report: Skeletal Muscle Lymphoma as a Result of Slow Centrifugal Migration of Untreated Primary Neurolymphomatosis?

Estimation of the Internal Dose Imparted by 18F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography

Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PET/CT Imaging

Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?

Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid Carcinoma

Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase

F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Artifacts in the Abdomen and Pelvis

Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma

Case Report: Pleuropulmonary Blastoma in a 2.5-Year-Old Boy: 18F-FDG PET/CT Findings

Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR

Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence